Omada Health, Inc. Increase (Decrease) in Accounts Receivable
Omada Health, Inc. (OMDA) reported Increase (Decrease) in Accounts Receivable of $23.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-07
- Omada Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $16.97M, a 339.21% increase year-over-year.
- Omada Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $6.21M, a 4.46% decline year-over-year.
- Omada Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$7.16M.
- Omada Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $9.15M.
- Omada Health, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $12.36M, a 40.34% increase from fiscal 2024.
- Omada Health, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $8.80M, a 64.98% increase from fiscal 2023.
- Omada Health, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $5.34M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $23.18M 10-Q · filed 2026-08-07 | $16.02M derived: sum of 3 quarters · filed 2026-08-07 | $25.17M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $6.21M 10-Q · filed 2026-05-08 | -$951.00K derived: sum of 2 quarters · filed 2026-05-08 | $8.20M derived: sum of 3 quarters · filed 2026-05-08 | $12.07M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.00M derived: sum of 2 quarters · filed 2026-03-06 | $5.86M derived: sum of 3 quarters · filed 2026-08-07 | $12.36M 10-K · filed 2026-03-06 |
| 2025-09-30 | $9.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $13.02M derived: sum of 2 quarters · filed 2026-08-07 | $19.51M 10-Q · filed 2025-11-07 | $18.64M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $10.36M 10-Q · filed 2026-08-07 | $9.49M derived: sum of 3 quarters · filed 2026-08-07 | $9.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $6.50M 10-Q · filed 2026-05-08 | $5.63M derived: sum of 2 quarters · filed 2026-05-08 | $5.47M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$1.03M derived: sum of 2 quarters · filed 2026-03-06 | $8.80M 10-K · filed 2026-03-06 | |
| 2024-09-30 | -$158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $9.68M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $9.83M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $5.34M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |